Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection.
about
Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasisDetection of driver metabolites in the human liver metabolic network using structural controllability analysis.The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite controlNeutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophagesProduction of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensisEvaluation of α,β-unsaturated ketones as antileishmanial agents.Leishmania parasites possess a platelet-activating factor acetylhydrolase important for virulence.Antileishmanial activity of the essential oil from Tetradenia riparia obtained in different seasons.Platelet-activating factor increases reactive oxygen species-mediated microbicidal activity of human macrophages infected with Leishmania (Viannia) braziliensis.Host response of platelet-activating factor receptor-deficient mice during pulmonary tuberculosis.Exome Sequencing Identifies Two Variants of the Alkylglycerol Monooxygenase Gene as a Cause of Relapses in Visceral Leishmaniasis in Children, in Sudan.In Vitro and In Vivo Control of Secondary Bacterial Infection Caused by Leishmania major.Experimental infection of Leishmania (L.) chagasi in a cell line derived from Lutzomyia longipalpis (Diptera:Psychodidae).Cross-resistance of Leishmania infantum isolates to nitric oxide from patients refractory to antimony treatment, and greater tolerance to antileishmanial responses by macrophages.Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections.Nitric oxide plays a key role in the platelet-activating factor-induced enhancement of resistance against systemic candidiasis.Expression and Activity of COX-1 and COX-2 in Acanthamoeba sp.-Infected Lungs According to the Host Immunological Status.
P2860
Q28542988-89A2061B-C506-4807-8BC2-247A4C6EA570Q33623803-114F2B3C-3E57-4E5D-BD97-D4E2A9AD989FQ33689420-6411FA99-5630-4EAC-84FB-4FD3D7FB67B7Q33748586-9FFBD748-7676-4320-9035-AEA4C09A4E19Q35139747-82EF27C3-3226-448E-A38D-087820128E88Q35165095-4AF3996A-51CD-4537-B64E-B822806281EDQ35607871-0CDCA5A4-F79A-4574-8461-6E40C7CF473DQ36381469-14F49D1F-A28C-44F1-B434-98CAAD83893EQ36450338-130B5740-091D-4C41-A4CE-DD457F6CCC2CQ38614021-7112B42D-D088-4D53-A001-FB2C4D797ABDQ39584714-AAA3372F-5978-4B2D-91AD-8BFE2963D93CQ40053798-FDBF7722-3A4B-4E38-87A1-A3ED28584E0FQ40136470-31A61D85-5FE8-46FE-B982-8FFF966BB077Q40348700-36638657-98AB-40E7-8415-67A6B0E7663CQ40945954-542E0BAC-4AE6-4282-B164-9344CBCD392CQ42983153-F3C3D712-D3D0-4560-BB55-FA5768EAA484Q46074504-234C053F-4562-405A-847D-0E6B3EA4A722Q47232195-C5664CE9-3010-44B8-87A2-EBA20514386D
P2860
Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Essential role of platelet-act ...... hmania) amazonensis infection.
@en
Essential role of platelet-activating factor in control of Leishmania
@nl
type
label
Essential role of platelet-act ...... hmania) amazonensis infection.
@en
Essential role of platelet-activating factor in control of Leishmania
@nl
prefLabel
Essential role of platelet-act ...... hmania) amazonensis infection.
@en
Essential role of platelet-activating factor in control of Leishmania
@nl
P2860
P1476
Essential role of platelet-act ...... shmania) amazonensis infection
@en
P2093
P2860
P304
P356
10.1128/IAI.68.11.6355-6361.2000
P407
P577
2000-11-01T00:00:00Z